Research Analysts Issue Forecasts for ICON Public Limited’s FY2025 Earnings (NASDAQ:ICLR)

ICON Public Limited (NASDAQ:ICLR) – Stock analysts at Leerink Partnrs reduced their FY2025 EPS estimates for ICON Public in a research report issued on Friday, October 4th. Leerink Partnrs analyst M. Cherny now anticipates that the medical research company will post earnings of $16.46 per share for the year, down from their prior estimate of $16.64. Leerink Partnrs currently has a “Strong-Buy” rating on the stock. The consensus estimate for ICON Public’s current full-year earnings is $14.54 per share. Leerink Partnrs also issued estimates for ICON Public’s FY2026 earnings at $18.45 EPS and FY2027 earnings at $20.53 EPS.

Several other research analysts also recently issued reports on the stock. Robert W. Baird lowered their price objective on shares of ICON Public from $368.00 to $340.00 and set an “outperform” rating on the stock in a research report on Friday, September 20th. Evercore ISI dropped their price target on ICON Public from $360.00 to $350.00 and set an “outperform” rating on the stock in a research report on Tuesday. Barclays reduced their price objective on ICON Public from $355.00 to $350.00 and set an “overweight” rating for the company in a research note on Friday, July 26th. Leerink Partners started coverage on ICON Public in a research note on Wednesday, September 18th. They issued an “outperform” rating and a $379.00 target price on the stock. Finally, Truist Financial restated a “buy” rating and set a $383.00 price target on shares of ICON Public in a research note on Wednesday, September 11th. One equities research analyst has rated the stock with a hold rating, eleven have given a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Buy” and an average target price of $353.60.

ICON Public Stock Down 1.0 %

Shares of NASDAQ ICLR opened at $287.56 on Monday. The business has a 50-day moving average price of $307.01 and a 200 day moving average price of $314.15. The stock has a market cap of $23.72 billion, a PE ratio of 34.98, a price-to-earnings-growth ratio of 1.32 and a beta of 1.22. The company has a quick ratio of 1.31, a current ratio of 1.31 and a debt-to-equity ratio of 0.36. ICON Public has a 52-week low of $221.20 and a 52-week high of $347.72.

ICON Public (NASDAQ:ICLR) last posted its earnings results on Wednesday, July 24th. The medical research company reported $3.75 earnings per share for the quarter, topping the consensus estimate of $3.68 by $0.07. ICON Public had a return on equity of 12.06% and a net margin of 8.57%. The firm had revenue of $2.10 billion during the quarter, compared to analysts’ expectations of $2.14 billion. During the same quarter in the previous year, the business earned $2.96 earnings per share. The firm’s revenue was up 4.1% compared to the same quarter last year.

Institutional Investors Weigh In On ICON Public

A number of large investors have recently added to or reduced their stakes in ICLR. Liontrust Investment Partners LLP grew its position in shares of ICON Public by 19.5% in the second quarter. Liontrust Investment Partners LLP now owns 119,728 shares of the medical research company’s stock valued at $37,531,000 after purchasing an additional 19,546 shares during the last quarter. Kornitzer Capital Management Inc. KS grew its holdings in ICON Public by 15.9% during the 2nd quarter. Kornitzer Capital Management Inc. KS now owns 95,753 shares of the medical research company’s stock valued at $30,016,000 after buying an additional 13,163 shares during the last quarter. State of Tennessee Treasury Department increased its position in ICON Public by 4.9% during the fourth quarter. State of Tennessee Treasury Department now owns 155,797 shares of the medical research company’s stock worth $44,101,000 after buying an additional 7,270 shares in the last quarter. Sara Bay Financial acquired a new position in shares of ICON Public in the third quarter worth $1,143,000. Finally, SkyView Investment Advisors LLC acquired a new position in shares of ICON Public in the first quarter worth $1,021,000. 95.61% of the stock is owned by institutional investors and hedge funds.

ICON Public Company Profile

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies.